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DObjective: Pulmonary venous obstruction (PVO) is an important cause of late mortality in total anomalous pul-
monary venous connection (TAPVC). We aimed to describe current practices for the management of postoper-
ative PVO and the efficacy of the different interventional procedures.
Methods: We conducted a retrospective international collaborative population-based study involving 19 pedi-
atric cardiac centers in the United Kingdom, Ireland, and Sweden. Patients with TAPVC born between January
1, 1998, and December 31, 2004, were identified. Patients with functionally univentricular circulation or atrial
isomerism were excluded. All available data and images were reviewed.
Results: Of 406 patients undergoing repair of TAPVC, 71 (17.5%) had postoperative PVO. The diagnosis was
made within 6 months of surgery in 59 (83%) of the 71 patients. In 12, serial imaging documented change in
appearance of the pulmonary veins. Good-sized pulmonary veins can progress to diffusely small veins and rarely
atresia. Patients presenting after 6 months had less severe disease; all are alive at most recent follow-up. Fifty-six
(13.8%) of 406 patients underwent intervention for postoperative PVO: 44 had surgical treatment and 12 had an
initial catheter intervention. One half underwent 1 or more reinterventions. Three-year survival for patients with
postoperative PVO was 58.7% (95% confidence intervals, 46.2%-69.2%) with a trend that those having a sur-
gical strategy did better (P¼ .083). Risk factors for death included earlier presentation after TAPVC repair, dif-
fusely small pulmonary veins at presentation of postoperative PVO, and an increased number of lung segments
affected by obstruction.
Conclusions: Postoperative PVO tends to appear in the first 6 months after TAPVC repair and can be progres-
sive. Early intervention for PVO may be indicated before irreversible secondary changes occur. (J Thorac Car-
diovasc Surg 2013;145:1255-62)There is ongoing late mortality in patients with total anom-
alous pulmonary venous connection (TAPVC), frequently
associated with postoperative pulmonary venous obstruc-
tion (PVO). Studies have shown that postoperative PVO
can occur in 5% to 18% of patients.1-8
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Abbreviations and Acronyms
CI ¼ confidence interval
CT ¼ computed tomography
HR ¼ hazard ratio
MRI ¼ magnetic resonance imaging
PVO ¼ pulmonary venous obstruction
TAPVC ¼ total anomalous pulmonary venous
connection
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Dof 71 patients with postoperative PVO describing presenta-
tion, morphologic features, intervention, and outcome of
the interventions.
Owing to the relative rarity of TAPVC and postoperative
PVO, previous studies have had to span a wide range of sur-
gical eras to obtain sufficient patients for analysis. The aim
of this study was to examine the prevalence, treatment, and
outcome of the cohort of patients with postoperative PVO in
a contemporary international population-based study.METHODS
The UK, Ireland and Sweden Collaborative study of TAPVC is a retro-
spective population-based study of all children born with this disease be-
tween January 1, 1998, and December 31, 2004, in the United Kingdom,
Republic of Ireland (hereafter denoted as Ireland), and Sweden.9 Patients
with functionally univentricular circulation or atrial isomerism were ex-
cluded. Ethics committee approval was obtained. The methodology has
been described previously.9
The records of each of the patients undergoing surgical repair of TAPVC
were assessed for postoperative PVO. Ninety percent of all postoperative
diagnostic angiography, 54% of diagnostic magnetic resonance imaging
(MRI)/computed tomography (CT) imaging, and 30% of diagnostic echo-
cardiography performed were directly visualized and reinterpreted by 2 in-
vestigators (A.N.S., J.P.) along with all catheterization and operative
reports. Pulmonary veins were considered to be obstructed on echocardiog-
raphy if the pulsed wave pulmonary venous Doppler pattern showed non-
phasic flow or velocities greater than 2 m/s.10 Angiographic diagnosis of
PVO was gained either from the levophase of pulmonary arterial injection
or from direct injection of contrast into the individual pulmonary veins.
Pulmonary veins were considered to be obstructed if the pulmonary vein
diameter was reduced by 50% or more from the largest measured dimen-
sion. The hemodynamic criterion for PVO was a mean gradient across the
stenosis of 4 mm Hg or more.5 All available pathologic reports were
studied.
In this cohort with postoperative PVO, the morphologic features as-
sessed comprised the following:
1. Unilateral or bilateral obstruction at presentation of postoperative PVO
2. Type of obstruction: the pulmonary veins were put into 1 of 2 categories
on the basis of qualitative observations—either discrete stenosis with
normal-sized pulmonary veins or stenosis with diffusely small pulmo-
nary veins
3. Site of PVO
4. Progression of obstruction
5. Pulmonary venous collateral circulation
The angiogram was reviewed in the frontal projection, and lung zones
affected by PVO were documented (upper and lower zones).1256 The Journal of Thoracic and Cardiovascular SurStatistical Methods
Risk factors with continuous distribution were expressed as median
(minimum-to-maximum) and categorical risk factors as number (percent).
Patient survival was described using Kaplan-Meier curves, and Cox pro-
portional hazards modeling was used to test the association between poten-
tial risk factors and death. Ninety-five percent confidence intervals (CIs)
were quoted (STATA 10; Stata Corporation, College Station, Tex). Multi-
variable analysis was not possible owing to the relatively small number of
patients and variables.RESULTS
Four hundred twenty-two live births with TAPVC were
identified, and 406 of these infants underwent surgical re-
pair; 71 (17.5%) of the 406 had evidence of postoperative
PVO.9 These 71 are the subject of this report. Surgery
was performed in multiple institutions by many different
surgeons as previously described.9 A wide variation in sur-
gical technique was noted.
Presentation of Postoperative PVO
PVOwas diagnosed 0 days to 5.2 years (median, 49 days)
after TAPVC repair, including 4 patients in whom obstruc-
tion was identified in the operating room at the time of pri-
mary repair. Two of these 4 patients died 4 and 9 days after
TAPVC repair and had hypoplastic and stenotic individual
veins at autopsy. The other 2 were known to have mild re-
sidual obstruction.
In an additional 12 patients, PVO was diagnosed before
initial hospital discharge. Ten of them underwent repeat sur-
gery during the same admission for attempted relief of
PVO. A total of 65 (92%) of the 71 achieved hospital dis-
charge, with 55 cases of PVO being diagnosed after initial
hospital discharge. Among these 65 patients, 8 were rela-
tively asymptomatic with evidence of obstruction being
found during routine follow-up; 4 had no intervention inas-
much as the disease was very mild. The others (n ¼ 57) ex-
hibited breathlessness and/or failure to thrive. Overall, 59
(83%) of 71 cases of PVO were diagnosed within 6 months
of initial surgery.
Diagnostic Imaging for the Presence of PVO
All patients underwent echocardiography. No further im-
aging was performed in 21 (30%), including 2 who died be-
fore further investigation could be performed. Thirty-eight
(54%) had angiography, and 7 also had MRI and/or CT
imaging.
Morphology
Of the 71 patients, 25 had supracardiac, 25 infracardiac,
11 mixed, and 9 cardiac site of connection. There was also 1
with common pulmonary vein atresia. This represents 25
(12%) of 205 in the overall cohort with supracardiac
TAPVC, 25 (23%) of 110 in the cohort with infracardiac
TAPVC, 11 (30%) of 37 in the cohort with mixed TAPVC,
and 9 (13%) of 67 in the cohort with cardiac TAPVC.gery c May 2013
FIGURE 1. Example of progressive change in the size of the right upper pulmonary vein (RUPV) in a patient with mixed total anomalous pulmonary ve-
nous connection (TAPVC). (A) Before TAPVC repair, a good-sized RUPV connects to the proximal superior vena cava (SVC). (B) After TAPVC repair and
attempted surgical relief of RUPVobstruction, the RUPVappears to be diffusely small (<) after injection of contrast into the right upper pulmonary artery
(RUPA). Time between angiograms was 2.4 years. LA, Left atrium.
TABLE 1. Initial intervention for relief of postoperative PVO (n¼ 56)
Procedure No. No. alive
Conventional balloon angioplasty 11 7
Cutting balloon angioplasty 1 1
Anastomotic/PV enlargement with pericardial patch 12 3
Anastomotic/PV enlargement with PTFE 3 1
Anastomotic/PV enlargement with native LA tissue 8 5
PV plasty/dilatation/endarterectomy 6 5
Redo coronary sinus unroofing 2 2
Right PVs/anastomotic enlargement with sutureless
pericardial patch. Left PV enlargement with LA
appendage
1 1
Right PVs/anastomotic enlargement with sutureless
pericardial patch
1 1
Enlargement of the PV channel by suturing veins together 2 1
Excision of fibrous ridge 1 0
Excision of stenosis, redo of shrunken ASD patch 1 1
Enlargement of anastomosis by extending the incision 3 3
Redo homograft patch diverting blood into LA and
enlargement of ASD
1 1
Unknown surgical details 3 1
PVO, Pulmonary venous obstruction; PV, pulmonary vein; PTFE, polytetrafluoro-
ethylene (Gore-Tex; W. L. Gore & Associates, Inc, Flagstaff, Ariz); LA, left atrium
(atrial); ASD, atrial septal defect.
Seale et al Congenital Heart Disease
C
H
DAt angiography, it was often difficult to differentiate
clearly whether a discrete obstruction was at the anastomosis
or separate and upstream from the anastomosis at the pulmo-
nary venous ostium.We therefore used the operation notes to
help localize the site of obstruction; however, these only de-
scribed the anatomy at the time of surgical intervention and
not at initial presentation. We had data on 50 of 52 children
having surgery at some point in their treatment for postoper-
ative PVO. Inmost cases themorphologic featureswere com-
plex, with narrowing at the anastomosis between the
confluence and the left atrium resulting in retraction and fi-
brosis of the surrounding tissues, which produced narrowing
at the entrance of the pulmonary veins. In rare cases (n¼ 6),
the surgical report stated that the stenosis was at the pulmo-
nary vein ostium with the anastomosis being unaffected.
Fifty-four patients had bilateral and 15 had unilateral
PVO: 8 on the right and 7 on the left. In 2, the pattern of ste-
nosis was unclear. At presentation, 35 had discrete stenosis
with normal-sized pulmonary veins, 14 had stenosis with
‘‘small’’ pulmonary veins as defined in the Methods section
(9 of whom had small pulmonary veins before TAPVC re-
pair), and in 22 the presenting morphologic features were
not known. In 14, one or more of the pulmonary veins
was atretic.
In 19 (26.8%) of 71 patients, there were 2 or more angio-
graphic, CT, or MRI studies. In 12 of the 19, serial imaging
could document changes in the appearance of the pulmo-
nary veins over time. Time between studies where changes
were seen varied from 20 days to 2.4 years. Figure 1 illus-
trates how good-sized pulmonary veins progressed to dif-
fusely small pulmonary veins and, rarely, atresia after
obstruction. If unilateral, the pulmonary artery became
small on the same side. One patient progressed from unilat-
eral to bilateral disease. In 16 patients, venovenous collat-
erals of varying sizes formed, draining to the systemic
veins or other lesser-affected parts of the pulmonary venous
bed. In half, the collateral system formed extensiveThe Journal of Thoracic and Carnetworks; in 1 case a pulmonary venous collateral crossed
the midline to the unaffected lung.INTERVENTION FOR POSTOPERATIVE PVO
Sixty (14.8%) of the 406 undergoing surgical repair of
TAPVC had postoperative PVO requiring intervention.
Four patients either died before intervention could be per-
formed or were awaiting intervention at last follow-up;
therefore, 56 (13.8%) of 406 underwent intervention for
postoperative PVO. Half (28/56) required more than 1
intervention.
This was an observational study, and the choice of inter-
vention was made by the treating physician. Forty-four haddiovascular Surgery c Volume 145, Number 5 1257
FIGURE 2. Interventions performed for postoperative pulmonary venous obstruction. Int cath, Interventional catheter.
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Dan initial surgical intervention and 12 an initial catheter
intervention. Table 1 details the initial interventions per-
formed and Figure 2 outlines further procedures performed.
Patients having an initial catheter intervention had a higher
pulmonary artery/systemic blood pressure ratio, but other-
wise there were no significant morphologic differences
between the catheter and surgical groups (Table 2).TABLE 2. Clinical comparison of patients undergoing initial catheter (n ¼
Cathete
Pulmonary artery/systemic blood pressure ratio, median (IQR) 0.75
Discrete stenosis of 1 or more pulmonary veins 6
Lung segments involved
1 0
2 4
3 1
4 7
Unilateral disease 3
No collaterals 7
Minor collaterals 2
Major collaterals 3
Age (d) at intervention (median, IQR) 44
PVO, Pulmonary venous obstruction; IQR, interquartile range. *Number of patients in wh
1258 The Journal of Thoracic and Cardiovascular SurMany different types of surgical intervention were per-
formed, making analysis of individual procedures impossi-
ble. Altogether, 75 surgical procedures of various types
were performed on 52 patients, 10 using the sutureless tech-
nique (on 9 patients). The sutureless technique was only
used in 2 patients as the initial intervention for postopera-
tive PVO.12) or surgical (n ¼ 44) intervention for postoperative PVO
r intervention Surgical intervention P value No.*
(0.50, 0.89) 0.50 (0.44, 0.63) .049 16
(54.6%) 23 (76.7%) .168 41
54
(0%) 3 (7.1%) .401
(33.3%) 6 (14.3%)
(8.3%) 3 (7.1%)
(58.3%) 30 (71.4%)
(25.0%) 8 (18.6%) .624 55
(58.3%) 11 (55.0%) .622 32
(16.7%) 6 (30.0%)
(25.0%) 3 (15.0%)
(28,69) 47 (38,74) .632 56
om data were available.
gery c May 2013
FIGURE 3. Kaplan-Meier curves showing (A) survival of patients having surgical repair of total anomalous pulmonary venous connection (TAPVC), with
and without postoperative pulmonary venous obstruction (PVO), and (B) freedom from death or second reintervention for those having an initial surgical and
catheter intervention for postoperative PVO. Patients were censored in part B if they had a further catheter or surgical intervention or died. Of the interven-
tional catheter group, all underwent reintervention (n¼ 11) or died (n¼ 1) within a year of their first intervention for postoperative PVO. Time zero is the date
of initial TAPVC repair.
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4 cutting-balloon procedures (on 2 patients) and 4 stenting
procedures (on 3 patients); the remainder were conventional
balloon dilatations. Therewas 1 hybrid procedure performed.
Outcomes for Postoperative PVO
Median follow-up of all patients undergoing surgical re-
pair of TAPVC (n ¼ 406) was 2.9 years (range, 1 day to 8.4TABLE 3. Risk factors for (1) death in univariable analysis of the 71 p
reintervention in univariable analysis of the 56 patients who had an interv
Variable
Seventy-one patients wit
postop PVO
HR 95% CI
P
value N
Diffusely small pulmonary veins 6.54 2.5-17.07 <.001
Age at presentation with postop PVO (wk)y 0.87 0.81-0.93 .001
Time from initial repair to diagnosis of postop
PVO (wk)y
0.78 0.69-0.88 <.001
No. of lung segments involved 1.70 1.03-2.82 .038
No collaterals 1.00 Reference
Minor collaterals 0.85 0.17-4.19 .837
Major collaterals 2.94 0.88-9.77 .079
Pulmonary artery/systemic blood pressure ratioz 1.00 0.77-1.30 .982
Unilateral disease 0.34 0.10-1.13 .078
Cardiac TAPVC 1.00 Reference
Infracardiac TAPVC 1.06 0.29-3.91 .931
Mixed TAPVC 2.34 0.61-9.08 .217
Supracardiac TAPVC 1.04 0.28-3.85 .952
Obstruction before initial TAPVC repair 0.99 0.46-2.15 .984
PVO, Pulmonary venous obstruction;HR, hazard ratio; CI, confidence interval; TAPVC, tot
available. yThese risk factors are extremely similar/overlapping: both are included for int
tervention or during interventional catheter procedure.
The Journal of Thoracic and Caryears). Two patients died of causes unrelated to the heart.
Only 6 patients died more than 6 months after TAPVC re-
pair, all secondary to postoperative PVO. There were no
deaths after 3 years.9
All patients with PVO. Median follow-up for cases of
postoperative PVO was 2.3 years (range, 1 day to 8.1 years)
representing 192.0 person-years of follow-up; in that time
there were 29 deaths.atients in whom postoperative PVO was diagnosed and (2) death or
ention for postoperative PVO
h
Fifty-six patients that had an intervention for postop PVO
o.* HR 95% CI
P
value No.*
49 2.40 1.18-4.88 .016 41
71 0.99 0.97-1.00 .109 56
71 0.99 0.97-1.00 .109 56
69 1.13 0.81-1.58 .470 54
38 1.00 Reference 32
38 3.63 1.35-9.74 .010 32
38 1.03 0.37-2.90 .957 32
20 1.05 0.91-1.23 .508 16
70 0.74 0.33-1.67 .466 55
71 1.00 Reference 56
71 0.97 0.28-3.37 .957 56
71 1.46 0.38-5.67 .581 56
71 1.60 0.46-5.49 .458 56
68 1.43 0.72-2.83 .308 54
al anomalous pulmonary venous connection. *Number of patients in whom data were
erest. zData gained from either diagnostic cardiac catheterization before surgical in-
diovascular Surgery c Volume 145, Number 5 1259
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patients with postoperative PVO were 95.8% (95% CI,
87.5%-98.6%), 62.0% (49.7%-72.1%), and 58.7%
(46.2%-69.2%), respectively.9 This is significantly worse
(hazard ratio [HR] ¼ 4.70; P<.001; 95% CI, 2.80-7.87)
than that of patients without postoperative PVO, in whom
30-day, 1-year, and 3-year survivals were 94.0% (90.8%-
96.1%), 91.2% (87.6%-93.8%), and 91.2% (87.6%-
93.8%), respectively (Figure 3, A).
Analysis of the 71 patients with a diagnosis of postoper-
ative PVO showed that risk factors for death comprised dif-
fusely small pulmonary veins (HR, 6.5; 95% CI, 2.5-17.1;
P< .001) and an increased number of lung segments af-
fected (HR, 1.70; 95% CI, 1.03-2.82; P ¼ .038) (Table 3).
The time between initial TAPVC repair and presentation
with postoperative PVO was also important; patients pre-
senting later with postoperative PVO did better (HR, 0.78;
95% CI, 0.69-0.88; P < .001). None of the patients in
whom postoperative PVO appeared later than 6 months after
TAPVC repair died. All had discrete obstruction rather than
diffusely small pulmonary veins at presentation. Two re-
quired repeat interventions owing to restenosis but both sur-
vived; the disease process of PVO was less severe in the late
presenters. Age at presentation with postoperative PVO is
a similar/overlapping variable and not surprisingly was im-
portant, with older patients presenting with postoperative
PVO doing better (HR, 0.87; 95% CI, 0.81-0.93; P¼ .001).
Patients with PVO undergoing intervention. Among the
patients undergoing intervention for postoperative PVO
(n ¼ 56), there appears to be a trend for the surgical group
to fare better than the catheter group with better freedom
from death or reintervention; however, this was not statisti-
cally significant (HR, 0.55; CI, 0.28-1.08; P ¼ .083)
(Figure 3, B). In these 56, patients with diffusely small pul-
monary veins at diagnosis of postoperative PVO did worse
than those with discrete stenosis (HR, 2.40; 95% CI, 1.18-
4.88; P ¼ .016) (Table 3). When collaterals were present,
patients with a poorly formed collateral system did worse
(HR, 3.63; 95% CI, 1.35-9.74; P<.010).
DISCUSSION
The UK, Ireland and Sweden Collaborative study of
TAPVC differs from other studies of this disease because
it is international, multicenter, and population-based, en-
abling a relatively large number of patients to be identified
within a short time period. This gives insight into contem-
porary management of the disease in contrast to other stud-
ies, which frequently study patients over several decades to
gather sufficient patients.
Incidence of Postoperative PVO
We found a relatively high incidence of PVO compared
with other series reported recently.6 This is likely to be
a result of our methodology. Because our study is1260 The Journal of Thoracic and Cardiovascular Surpopulation- rather than intervention-based, we captured
all, or very nearly all, patients with postoperative PVO.
This includes those who died before intervention and those
with mild obstruction insufficient to warrant intervention.Diagnosis of Postoperative PVO
In 83% of the patients with postoperative PVO, the diag-
nosis was made in the first 6 months after TAPVC surgery.
Typically, a continuous-flow pattern on pulsed wave Dopp-
ler, rather than the maximum velocity of pulmonary venous
flow, alerted the clinician to obstruction. With postoperative
TAPVC, all the flow goes through 1 orifice and the flow pat-
tern is dependent on its relative size. Echocardiography
alone may not diagnose and describe the anatomy ade-
quately, particularly where only 1 vein is involved.10 Con-
versely, there were several examples in which PVO was
suspected on echocardiography but subsequently excluded
by angiography, CT, or MRI. In view of this, we believe
that all patients with suspected PVO should have additional
imaging to echocardiography to delineate the anatomy and
enable early diagnosis of postoperative PVO. It is possible
that in this group with postoperative PVO, some mild resid-
ual obstruction may have been present immediately after
initial repair of TAPVC but not recognized. With recent im-
provements in noninvasive imaging technology, visualiza-
tion of the pulmonary veins has improved greatly,
especially with high-resolution CTangiography andMRI.11Morphology and Progression
Our previous work showed the significant morphologic
spectrum found in TAPVC.9 Our previous publication has
shown that preoperative features do have a role in the devel-
opment of postoperative pulmonary vein stenosis.9 In par-
ticular, multivariable risk factors for postoperative PVO
comprised preoperative hypoplastic/stenotic pulmonary
veins and absence of a common confluence.9 Most cases
of mixed TAPVC will not have a single confluence, and in-
deed 30% of the whole cohort with mixed TAPVC devel-
oped postoperative pulmonary vein stenosis. Some have
speculated that newer surgical techniques such as a primary
sutureless repair may help prevent postoperative PVO.12
Recent reports are encouraging.13,14
There appear to be 2 groups of patients with postopera-
tive PVO:
1. Young patients presenting early (<6 months) after
TAPVC repair, often within the first few weeks, gener-
ally with aggressive and progressive obstruction
2. Older patients presenting later with milder and less pro-
gressive disease
In our study, the 12 patients presenting more than 6
months after TAPVC surgery are all alive at latest
follow-up.gery c May 2013
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with more diffuse disease of the individual pulmonary veins
tended to have more rapid progression and died. Hyde and
colleagues4 similarly found that median time to interven-
tion was shorter in patients with stenosis of the individual
veins compared with purely anastomotic obstruction. Ricci
and associates15 also found early presentation of postoper-
ative PVO to be a risk factor for death. The results of our
study support these findings. We found that (1) diffusely
small pulmonary veins at diagnosis of postoperative ob-
struction and (2) a shorter time between initial TAPVC re-
pair and presentation with obstruction were both risk factors
for death. All but 1 of the patients with diffusely small pul-
monary veins presented within 3 months of TAPVC sur-
gery. Of those presenting after 6 months of TAPVC
surgery, all had discrete obstruction rather than diffusely
small pulmonary veins.
The way the pulmonary veins react to obstruction after
TAPVC repair is similar to that seen in pulmonary vein
stenosis owing to other causes, suggesting a possible
common mechanism. We16 have previously shown that
PVO tends to progress; in some cases venovenous collat-
eral vessels will form, and a major collateral system can
be a protective feature.16 Unfortunately, we had limited
access to postmortem data and were unable to study his-
tologic characteristics. The pathologic mechanisms re-
sponsible for progression of PVO need to be elucidated.
It is possible that some patients have genetic factors
that may predispose them to development of stenosis.17
Further investigation is needed to examine the histologic
and biochemical pathways responsible for all forms of
PVO; this is likely to require a pathology-based prospec-
tive collaborative multicenter study.
Owing to the progressive nature of PVO, early interven-
tion before irreversible secondary changes occur may be in-
dicated. We have shown poor outcome when the pulmonary
veins have become diffusely small.
Interventions
Institutions with significant experience with the suture-
less technique have recently reported encouraging short-
and medium-term outcomes.18,19 We had anticipated
finding more examples of this technique, but only 9
patients had a sutureless repair. This may reflect the time
period of our study (1995-2004) compared with when the
technique was published (1996 and 1998)20,21 and
reluctance to adopt a new technique in the absence of
long-term outcome data.
Many different surgical20-22 and catheter23-25 techniques
exist to treat PVO. The plethora of interventions and the
small numbers in each group made comparative analysis
problematic. In addition, as morphologic features of
pulmonary vein stenosis varied, surgeons altered
technique to account for individual patient’s anatomy,The Journal of Thoracic and Carmaking analysis even more difficult. Future studies
comparing techniques to treat postoperative PVO should
be prospective, consider pulmonary vein morphologic
features, and consider severity of the disease. A
pulmonary vein score, such as that devised by Yun and
colleagues,18 would help evaluate outcomes of different
interventions.
Our data show a trend toward lower reintervention rate in
those undergoing an initial surgical rather than catheter ap-
proach for postoperative PVO. This was, however, not sta-
tistically significant. This is similar to our findings in
patients having intervention for primary pulmonary vein
stenosis.16 We should be wary in interpreting these data in-
asmuch as the underlying morphologic substrate may have
been different. For example, an initial catheter strategy may
have been chosen for sicker patients with more diffuse ste-
nosis including disease in the individual pulmonary veins.
This is supported by our data, which show a statistically
higher pulmonary/systemic pressure ratio in those undergo-
ing an initial catheter procedure. Likewise, patients under-
going surgical repair using polytetrafluoroethylene
(Gore-Tex; W. L. Gore & Associates, Inc, Flagstaff, Ariz)
or bovine pericardium appeared to fare less well, but this
may simply reflect patients with more severe disease requir-
ing more extensive reconstruction (Table 1).
Owing to the progressive nature of this disease, the most
important factor is whether complete abolition of the steno-
sis is achieved. Clinicians should strive for this, whichever
technique is used.Study Limitations
Owing to the collaborative and observational design of
the study, there was considerable variation in surgical tech-
nique. Owing to different patients, centers, and operators,
the study design is not optimal for comparing different inter-
ventions. In addition, although this is a large study, numbers
are still too small to assess the relative advantages of individ-
ual interventions clearly. Relatively small numbers also pre-
vented us performing a meaningful multivariable analysis.CONCLUSIONS
We have identified a cohort of patients in whom PVO de-
veloped after surgical repair. PVO after repair of TAPVC re-
mains a difficult and complex disease to treat, with 40% of
patients dying within 3 years of TAPVC repair. Postopera-
tive PVO usually develops in the first 6months after surgical
repair and is progressive. Close observation is required dur-
ing this period, with further imaging being performed if
there is any suspicion of postoperative PVO. In younger pa-
tients, postoperative PVO is frequently progressive, with
pathologic remodeling of the pulmonary venous bed. The
mechanisms remain unknown and need further clarification.
Early intervention may be indicated before irreversiblediovascular Surgery c Volume 145, Number 5 1261
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H
Dchanges occur. Patients presenting later than 6 months after
TAPVC repair appear to have a less progressive course.
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